Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Exit

Pliant places IPO terms
Existing investor Novartis has committed to a $10m private placement alongside the IPO, in which the fibrosis therapy developer, based on UCSF research, is set to raise up to $96m.
Apple picks up Inductiv
Apple has bought Inductiv to integrate the latter's machine learning data cleanup expertise, based on Stanford, Wisconsin-Madison and Waterloo faculty innovations.
UA’s FreeFall Aerospace completes merger
UAVC-backed antenna technology spinout FreeFall Aerospace has merged with one of its clients in order to focus its efforts on 5G communications.
Nanoform to shape $76.7m IPO
Nanoform has filed for a dual listing in Sweden and Finland, marking the first time that a University of Helsinki spinout is seeking an initial public offering.
Abiomed absorbs Breethe
University of Maryland's respiratory support device spinout Breethe has been picked up by Abiomed, which aims to expand treatment options for cardiogenic shock patients.
Acacia circles over Woodford assets
Woodford has faced challenges in selling its shareholdings in spinouts including Oxford Nanopore and Immunocore, but has now lined up Acacia as a potential buyer.
Medallia to purchase Voci for $59m
Carnegie Mellon University call centre analytics software spinout Voci Technologies is to be acquired after raising $17.9m of equity and debt financing.
Digital.ai materialises through three-way merger
Following the January merger of XebiaLabs and CollabNet VersionOne, Purdue spinout Arxan Technologies has also joined the group, now dubbed Digital.ai.

Other News

Huma hits up Biobeats for acquisition
Huma has bought Surrey-founded wellness tracking app developer Biobeats to increase the number of digital biomarkers that underpin its services.
Invesco to exit unlisted UK portfolio companies
Invesco will sell its unquoted UK holdings to reallocate its capital to public stocks, meaning disruption for numerous spinouts and Oxford Sciences Innovation.
Niantic maps out 6D.ai acquisition
Niantic has purchased University of Oxford’s augmented reality engine developer 6D.ai and will use the spinout’s technology for large-scale mapping for its games.
Passage Bio pushes proceeds to $248m
Underwriters have exercised their over-allotment option in full, increasing the University of Pennsylvania-linked genetic medicine developer’s proceeds by $32.4m.
Boosted loses momentum
Electric skateboard producer Boosted, backed by Stanford-StartX Fund, has laid off employees after its business model succumbed amid the US-China tariff war.
Transphorm shapes reverse merger
The UC Santa Barbara-founded semiconductor technology producer has gone public through a reverse merger with penny stock company Peninsula Acquisition and received $21.5m from investors including Marelli.

Editor's Picks

Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
Big deal: Nucana and Nightstar race to public markets
Nucana, a Scottish Investment Bank-backed cancer treatment developer, and Nightstar Therapeutics, an Oxford spinout focused on retinal gene therapies, have entered the public market.
test reg

Login